Revenue is growing 14% again, but the scorecard is 1-of-4 with a Debt Risk flag, the P/E is 88x and return on assets is negative. Even so, 91% of 14 analysts rate it Buy, and the $271.18 average target implies about 20% upside with the stock 11% below its high. Current price: $225.63.
Changes over time: 2 discontinued (the 747 wide-body, production ended 2022; and Boeing Capital as a reportable segment, removed 2024), 2 New & Sustained, 2 Evolved, 2 New Products — a narrower commercial line-up and restructured financing reporting.
Boeing operates one half of a global commercial-aircraft duopoly with a multi-year order backlog, alongside a large defense and services franchise. The opportunity is recovery: returning the 737, 777X and 787 programs to stable, profitable production while defense and services provide ballast. Revenue is growing 14% as deliveries ramp, but the path runs through execution and balance-sheet repair.
Boeing's long-term value rests on its intellectual property, brand and the sheer scale of its backlog — but the current returns picture is distressed rather than compounding. Reported return on equity (about 170%) is distorted by a very thin, heavily-levered equity base and is not meaningful; the more conservative return-on-assets proxy is negative (about -2%), and restnvest flags both Debt Risk and Growth With Low Returns. Value creation here is a turnaround thesis, not present-day cash compounding.
Y = price target. X = days remaining on call (negative = past expected hit window). Bubble size = Anachart Performance Score. Dashed vertical = the expected-hit boundary.
Chart shows 5 of 14 covering analysts. See all on Anachart →
Boeing is a turnaround priced as a near-certainty. The encouraging signal is real — revenue is growing 14% as the 737, 777X and 787 programs ramp — but almost everything else in the scorecard is strained: restnvest marks fundamentals 1-of-4 with Debt Risk and Growth With Low Returns, valuation 0-of-4 sensible, and the numbers behind it are difficult. The trailing P/E is 88x on barely-positive earnings, the free-cash-flow margin is 2.8%, and returns are distressed: reported return on equity near 170% is meaningless against a thin, heavily-levered equity base, so the conservative return-on-assets proxy of about -2% is the more honest read. Against that, 91.3% of 14 analysts rate it Buy with a 70.63% hit ratio and a $271.18 average target implying about 20% upside, anchored by the multi-year backlog and defense and services ballast — though the single Hold (Morgan Stanley's Kristine Liwag at $250) and the high-target Buys (Jefferies and Tigress at $295) frame the spread. A long-term investor weighs a duopoly franchise with a recovering top line against a balance sheet and earnings base that have not yet caught up to the optimism. Two data notes: return on equity was set aside as distorted, so the roicPercent shown reflects the conservative ROA proxy; and one visible analyst (Tigress's Feinseth) had no average-days-to-target on file, so that name's days-remaining figure is estimated from the ticker-level average.
Dive deeper into the fundamentals
See Boeing's full 6-stage analysis on restnvest →See the full analyst picture
See all 14 analyst price targets on Anachart →